Presidio Partners 2007 GP, LLC is 10% Owner at Neos Therapeutics, Inc. (NEOS). They have made 1 open-market trade across 1 company since 2016, most recently 2016-04-20.
CIK 0001425391
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NEOS | 40,393 | $46K |
Shares reported on the most recent Form 4, priced at the 2016-04-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NEOS | SELL | 2016-04-18 | 2016-04-20 | $9.97 | $357K | -5.1% | -20.1% | -8.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.